Mark Slee

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 547 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 416 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Defining reliable disability outcomes in multiple sclerosis

Tomáš Kalinčík, Gary Cutter, Tim Spelman et al. · Brain · 2015 · 243 citations · Full text

Medicine, Neurology, Disability Management +16

Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

María Trojano, Guglielmo Lucchese, Giusi Graziano et al. · PLoS ONE · 2012 · 237 citations · Full text

Social Sciences, Neurology, Epidemiology +14

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Tomáš Kalinčík, Vilija Jokubaitis, Jeannette Lechner‐Scott et al. · Brain · 2013 · 194 citations · Full text

Medicine, Neurology, Clinical Epidemiology +14